Form 4 for MDGL MADRIGAL PHARMACEUTICALS, INC.
Accepted 2026-08-20 16:20:52 ET · period of report 2026-08-17 · accession 0001628280-26-058256 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-20 16:20 | 2026-08-17 | MDGL | Kelley Shannon T | GC | S - Sale | $514.97 | -664 | 11.5K | -5% | -$341.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-17 | S | D | 664 | $514.97 | 11,474 | D | — | — | (F1) This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person. |